Zinc Carnosine is a stable chelating compound formed by creatine and zinc ions. It has been confirmed through multiple clinical and basic studies that it mainly maintains intestinal health through three core mechanisms: targeted repair of intestinal mucosal barrier, inhibition of intestinal inflammation cascade reaction, and regulation of intestinal microbiota homeostasis. It is a functional raw material with clear evidence-based basis in the field of intestinal health.
From the perspective of basic properties, creatine zinc is composed of β - alanyl-L-histidine (creatine) and zinc chelated in a 1:1 molar ratio. Unlike inorganic zinc and ordinary organic zinc salts, its unique molecular structure can achieve targeted release in the intestine, significantly reducing the gastrointestinal irritation of free zinc and improving bioavailability. At the level of its mechanism of action, firstly, creatine zinc can upregulate the expression of occludin and claudin, tight junction proteins in intestinal epithelial cells, promote epithelial cell proliferation and migration, accelerate damaged mucosal healing, repair intestinal barrier integrity, and reduce endotoxin and antigen influx into the bloodstream; Secondly, this ingredient can eliminate excessive reactive oxygen species in the intestine and exert antioxidant effects, while inhibiting the activation of the NF - κ B pro-inflammatory pathway, downregulating the levels of pro-inflammatory factors such as TNF - α and IL-6, and alleviating intestinal mucosal inflammatory damage; Thirdly, Zinc Carnoside can inhibit the adhesion and colonization of pathogenic bacteria, while not interfering with the growth of beneficial bacteria such as Bifidobacterium and Lactobacillus, maintaining the balance of intestinal microbiota.
At the level of industrial application, Zinc Carnoside can be adapted to multiple B-end application scenarios. The core solution includes enteric coated capsules and chewable tablets for oral dietary supplements, with clinically validated effective doses of 75mg per day (corresponding to 16mg of Zinc and 59mg of Carnoside); A nutritional support preparation for special medical formula foods, targeting individuals with intestinal mucosal damage and absorption disorders; It can also be used for the development of pharmaceutical excipients related to the gastrointestinal tract. In terms of industry trends, the global intestinal health raw material market continues to expand, and downstream demand for evidence-based and safe raw materials continues to increase. Carnosine zinc, with its clear mechanism of action, sufficient clinical data, and excellent formulation adaptability, is gradually replacing traditional zinc salts as the core raw material in the intestinal health track. Its application penetration rate in the fields of dietary supplements and specialty foods in Europe, America, and the Asia Pacific region is increasing year by year.